Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -4.44% 21.50p 21.00p 22.00p 22.50p 19.25p 22.50p 1,114,460 13:12:02
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -7.2 -4.5 - 44.00

Futura Medical Share Discussion Threads

Showing 16201 to 16220 of 16825 messages
Chat Pages: Latest  649  648  647  646  645  644  643  642  641  640  639  638  Older
DateSubjectAuthorDiscuss
09/1/2019
09:10
j777j - I don't see any substance in anything you wrote in post 4755. I think my post is a lot more informative.
slaccs
09/1/2019
09:03
Another informative post.
j777j
09/1/2019
08:32
Well done. Amazing when you know Eli Lilly paid over $2.2 billion for a product that was selling $900 million a year. This from Growth company investor "Research suggests a 20% market share could be possible, equating to sales of $560m in major western markets. In time an OTC version could more than double this." Fum market cap £20 million. Could be 10 x that and still cheap! So many times UK investors just don't get it when anything to do with tech or bio,or in this case Medtech. Fum is a highly disruptive company.
j777j
09/1/2019
08:13
i send many mails to large pharmas in last days and provide them with infos about our undiscovered Goldmine . Got first response by Novartis ,i hope i can help our FUM to make a big Deal for MED or company getting bought .STRONG BUY Thanks xxxx. Will forward to our deal team to see if there is any interest. Kind Regards, Cory Twining Novartis Investor Relations Officer Mobile +1 862 246 0966 cory.twining@novartis.com From: Relations, Investor (Gen) Sent: Tuesday, January 8, 2019 9:55 AM To: Twining, Cory Subject: FW: Takeover candidate ?
ih_572003
09/1/2019
07:40
Thanks to Bernstein I certainly learned something new.. "my math is based on Cialis developer ICOS which got $75 million upfront payments after phase 2 results by Eli lilly and later getting bought for $2.2 BILLION . FUM is valued at 20 million and we have the wayyyyy better drug even at 50p it would be dirt cheap if P3 is successful ." They received $75 million after a Phase II trial and then ended up being bought for over $2.2 billion. Now I understand what JB might be on about with his "punchy numbers" comments. Also I see FUM is written up in this months Growth company investor newsletter.
j777j
09/1/2019
05:59
Déjà vu.
glavey
08/1/2019
16:26
lots of buyers and almost no sellers looks like next big leg is on the way
ih_572003
08/1/2019
14:42
All the old clowns like supergirl are back.Now claiming they bought the stock. Oh and if it gets manipulated down it's normal but if it rises it's a pump and dump.So much bitterness and jealousy in the world.Sad really.
j777j
08/1/2019
14:31
whatever i bought also around 7p and im super happy with that and not selling a single share before we hit 20p . FUM = Mcap 20 million /Cash balance 10.5 million (or 2 years of Cash) , 1 Approved Drug , 1 awaiting approval and the potential Blockbuster is close to Phase 3 readout = A lifetime opportunity here tgt £2-3 within 12-18 months .GLTA Furutra could get 20% of a US$5bn market Futura Medical PLC’s (LON:FUM) erectile dysfunction treatment, MED 2002 has the potential to be a US$1bn drug, new research has suggested. Sales of that magnitude would put the gel into the blockbuster category. Market research firm Ipsos, interviewed 400 men to asses the gel's potential as an OTC or without prescription product. Respondents indicated the rapid onset of action, an average of less than five minutes, was the key feature and could command a price premium compared with existing treatments such as Viagra and Cialis, which have a substantially slower onset. That made it 'highly differentiated' from the rivals. Ipsos, which a strong record in forecasting drug sales, predicts peak OTC or without prescription annual sales for MED2002 in excess of US$650mln, of which 70% would be in addition to previous estimates of a US$600mln prescription market. As a result, the estimated peak annual sales of MED2002 in prescription and OTC versions would be more than US$1bn under patent.
ih_572003
08/1/2019
14:28
Oh and the forecast you suggest there is a potential for £75 bill market cap here. Yes there are some muppets on ADVFN that will fall for your BS, best of luck and no doubt own you sell out the avatar will go dormant.
superg1
08/1/2019
14:09
ih The game is up me old fruit, I know how ADVFN have registered 100's of 1000's of false avatars. That is a fraud to do with Ad selling and claims re registered user numbers. I actually bought some FUM the other day but don't agree with this sort of total BS fraud pump and dump. Your plan is simple suck as many in as you can to dump your shares on. I have a friend or two invested that have lost plenty here, so I hope it does well for them this year. The first MED results news was a fraud by FUM and I did suggest investors should seek to get their cash back having been clearly misled. Hopefully later this year 2nd time around it will work on moderate and serious sufferers so those that were misled by JB can get some of their money back.
superg1
08/1/2019
14:04
superg its because i have an account as bernstein on investorshub but it shows as ih_572003 on this board i dont know why so please stop the conspiracy theory hehe .
ih_572003
08/1/2019
14:02
Just to test it I made a random one up ih_661999. That came out as lecmorneaqui1972 joined Feb 2018, no posts. Change the last number to an 8 and you get conmenragui1981 Yes you guessed it, joined Feb 2018 no posts. ADVFN staff up to fraud it seems to me.
superg1
08/1/2019
14:02
FUM = Mcap 20 million /Cash balance 10.5 million (or 2 years of Cash) , 1 Approved Drug , 1 awaiting approval and the potential Blockbuster is close to Phase 3 readout = A lifetime opportunity here tgt £2-3 within 12-18 months .GLTA Furutra could get 20% of a US$5bn market Futura Medical PLC’s (LON:FUM) erectile dysfunction treatment, MED 2002 has the potential to be a US$1bn drug, new research has suggested. Sales of that magnitude would put the gel into the blockbuster category. Market research firm Ipsos, interviewed 400 men to asses the gel's potential as an OTC or without prescription product. Respondents indicated the rapid onset of action, an average of less than five minutes, was the key feature and could command a price premium compared with existing treatments such as Viagra and Cialis, which have a substantially slower onset. That made it 'highly differentiated' from the rivals. Ipsos, which a strong record in forecasting drug sales, predicts peak OTC or without prescription annual sales for MED2002 in excess of US$650mln, of which 70% would be in addition to previous estimates of a US$600mln prescription market. As a result, the estimated peak annual sales of MED2002 in prescription and OTC versions would be more than US$1bn under patent.
ih_572003
08/1/2019
14:00
EG the one ending 003 is shown as Berstein Another ih name is shown as following but click on that and it's tincnuhypi1974 then the other one again ih is flavadigflag1974. Both joined Feb 2018 and no posts. Then those guys are shown as following other ih names. EG Flagdiv is shown as following 4 ih names which come out as Goldenbo, kzivan, BENJAMINS and radarjson. None have then have posted. On s screen they would come up as ih100 and 137, 147, 657 and 866. In short ADVFN have created load of false names starting ih100
superg1
08/1/2019
13:55
A few years ago i bought GW Pharma at $9 per share now it trades at $114 and ATh was over $170 . Now i see much more potential on FUM because ot its very low valuation of 20 million thats nothing for a company that own a potential MULTI BILLION Dollar drug which is wayy better than the Blockbuster Viagra and Cialis .
ih_572003
08/1/2019
13:38
Interesting that most think it worth millions etc, shame the market doesn't work the same, we all be millionaires by now than.
amrishbhim
08/1/2019
13:30
With approval of TPR100 next quarter and licensing deals for TPR100 and CSD500 this heavily underpriced stock could explode quickly to £1 . I LOVE ITTT
ih_572003
08/1/2019
13:16
Certainly gone up hard now but will it droop later!
wisteria2
08/1/2019
13:10
ups i mean it works light years better than viagra and cialis and could capture a very large market share in the $5.6 BILLION market . TGT £2-3 within 12-18 months RALLYYYYYYYYYYYYYY
ih_572003
Chat Pages: Latest  649  648  647  646  645  644  643  642  641  640  639  638  Older
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190523 12:42:27